Acorda Therapeutics Inc (ACORQ) Inventory Turnover Ratio, from first quarter 2024 to first quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Acorda Therapeutics Inc   (ACORQ)
 

Acorda Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Acorda Therapeutics Inc inventory turnover ratio, the Acorda Therapeutics Inc 's ability to sell and replace its inventory in the first quarter 2024, sequentially increased to 1 in the first quarter 2024, yet the ratio remained below the average, as ACORQ's market remain challenging.Average inventory processing period, for the Acorda Therapeutics Inc in Mar 31 2024 quarter, has decreased to 365 days, compare to 372 days, in the Dec 31 2023 quarter.

Within Healthcare sector 339 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2024, to 1836, from total ranking in the fourth quarter 2023 at 1838.

ACORQ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Acorda Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACORQ Inventory Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Inventory Growth 4.86 % 26.69 % 17.64 % -3.42 % -9.24 %
Y / Y Cost of Sales Growth 14.63 % 22.74 % -69.22 % -65.17 % -45.8 %
Inventory Turnover Ratio (TTM) 1 0.98 0.97 1.55 1.94
ACORQ's Total Ranking # 1836 # 1838 # 1840 # 1840 #
Average inventory processing period 365 372 378 235 188
Seq. Inventory Growth -12.6 % -9.96 % 21.25 % 9.89 % 5.59 %
Seq. Cost of Sales Growth -33.77 % 65.25 % 10.51 % -5.23 % -29.08 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 24
Healthcare Sector # 340
Overall Market # 1836

Inventory Turnover Ratio Statistics
High Average Low
2.74 1.82 0.97
(Dec 31 2014)   (Sep 30 2023)



ACORQ Company Profile >> Back to ACORQ Efficiency Comparisons >> Compare ACORQ Inventory Turnover Ratio to its Competitors

Financial Statements
Acorda Therapeutics Inc 's Inventories $ 14 Millions Visit ACORQ's Balance sheet
Acorda Therapeutics Inc 's Cost of Revenues TTM $ 16 Millions Visit ACORQ's Income Statement
What are ACORQ's Sales? Visit ACORQ's Sales by Segment

Other Inventory Turnover Ratios
Acorda Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ACORQ's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ACORQ's Competitors
Inventory Turnover Ratio for ACORQ's Suppliers
Inventory Turnover Ratio for ACORQ's Customers

You may also want to know
ACORQ's Sales Growth Rates ACORQ's Pe Price to earnings ratio ACORQ's Receivables Turnover Ratio ACORQ's Stock Quote
ACORQ's Net Income Growth Rates ACORQ's Ps Price to Sales ratio ACORQ's Sales per Employee ACORQ's Asset Turnover Ratio
ACORQ's Net Margin ACORQ's Pb Price to Book ratio ACORQ's Financial Strength Ratios ACORQ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2024 Inventories at quarter ending Mar 31 2024
Inotiv Inc   3.06 $ 157.844  Millions$ 52  Millions
Logicmark Inc  3.02 $ 3.167  Millions$ 1  Millions
Aquestive Therapeutics Inc   2.98 $ 20.483  Millions$ 7  Millions
Msa Safety Inc  2.97 $ 936.000  Millions$ 315  Millions
Alnylam Pharmaceuticals Inc   2.97 $ 281.397  Millions$ 95  Millions
Mettler toledo International Inc   2.95 $ 1,130.343  Millions$ 383  Millions
Electromed Inc   2.95 $ 12.621  Millions$ 4  Millions
Neogen Corporation  2.94 $ 453.991  Millions$ 154  Millions
Dentsply Sirona Inc   2.93 $ 1,867.000  Millions$ 636  Millions
Caredx Inc   2.93 $ 55.978  Millions$ 19  Millions
Sonoma Pharmaceuticals Inc   2.93 $ 7.990  Millions$ 3  Millions
Illumina Inc   2.89 $ 1,737.000  Millions$ 601  Millions
Iridex Corp  2.85 $ 30.000  Millions$ 11  Millions
Abbott Laboratories  2.85 $ 18,107.000  Millions$ 6,363  Millions
Amneal Pharmaceuticals Inc   2.83 $ 1,615.000  Millions$ 570  Millions
Amphastar Pharmaceuticals Inc   2.83 $ 308.828  Millions$ 109  Millions
Hologic Inc  2.81 $ 1,816.000  Millions$ 645  Millions
Koru Medical Systems Inc   2.81 $ 11.658  Millions$ 4  Millions
Angiodynamics Inc   2.78 $ 159.209  Millions$ 57  Millions
Coherus Oncology inc   2.77 $ 176.704  Millions$ 64  Millions
Transmedics Group Inc   2.74 $ 111.630  Millions$ 41  Millions
Dexcom Inc   2.73 $ 1,413.100  Millions$ 517  Millions
Zynex inc   2.69 $ 38.395  Millions$ 14  Millions
Zai Lab Limited  2.65 $ 108.098  Millions$ 41  Millions
Lifevantage Corp  2.65 $ 41.682  Millions$ 16  Millions
Mimedx Group Inc   2.63 $ 53.581  Millions$ 20  Millions
Quidelortho Corp  2.63 $ 1,484.800  Millions$ 564  Millions
Skinhealth Systems Inc   2.63 $ 242.826  Millions$ 92  Millions
Sonendo Inc   2.56 $ 30.622  Millions$ 12  Millions
Perrigo Company Plc  2.56 $ 2,932.000  Millions$ 1,145  Millions

Date modified: 2026-08-29T17:28:08+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.